Edition:
United States

Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

26.36USD
2:25pm EST
Change (% chg)

$-0.19 (-0.72%)
Prev Close
$26.55
Open
$26.34
Day's High
$26.79
Day's Low
$26.22
Volume
39,207
Avg. Vol
219,204
52-wk High
$28.90
52-wk Low
$11.30

Select another date:

Tue, Nov 7 2017

BRIEF-Arena Pharmaceuticals reports Q3 loss per share $0.86

* Arena Pharmaceuticals provides corporate update and reports third quarter 2017 financial results

BRIEF-Arena Pharmaceuticals Q2 loss per share $0.77

* Arena Pharmaceuticals provides corporate update and reports second quarter 2017 financial results

BRIEF-Arena Pharmaceuticals says public offering of 6.25 mln common shares priced at $24 per share

* Arena Pharmaceuticals announces pricing of public offering of common stock

BRIEF-Arena Pharmaceuticals announces proposed public offering of common stock

* Arena Pharmaceuticals announces proposed public offering of common stock

Arena's heart-lung drug succeeds in mid-stage study, shares soar

U.S. drug developer Arena Pharmaceuticals Inc said on Monday its experimental drug for pulmonary arterial hypertension (PAH), a rare but deadly lung disease, met the main goal in a mid-stage study.

BRIEF-Arena Pharmaceuticals Inc's board increased size of board from nine directors to ten directors

* Arena Pharmaceuticals Inc - on June 13, 2017, board of directors increased size of board from nine directors to ten directors Source text:(http://bit.ly/2rAYXbA) Further company coverage:

BRIEF-Arena Pharmaceuticals says shareholders and board approve reverse stock split

* Arena Pharmaceuticals announces shareholders and board of directors approve reverse stock split

Select another date: